Latest News and Press Releases
Want to stay updated on the latest news?
Featured Releases
-
Dismissal of Federal Securities Class Action Lawsuit Follows Dismissal of Related Shareholder Derivative Lawsuit New York, NY, Jan. 09, 2026 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ:...
Read More -
CHICAGO, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Numerator, a data and technology company providing insights into consumer behavior, released its December 2025 Numerator Consumer Price Index (CPI) with an...
Read More
-
Micro-Fulfillment Market size was valued at US$ 6,492.29 Million in 2024, expanding at a CAGR of 41.20% from 2025 to 2032.
-
New subgroup analysis shows consistent, clinically meaningful pain reduction observed from Stage 2 through Stage 4 disease, including late-stage patients with otherwise limited treatment options THE...
-
PDS Biotech Submits Amended Protocol for Phase 3 VERSATILE-003 Trial Constructive Type C Meeting Provides Potential Pathway to Accelerated Approval of PDS0101 PRINCETON, N.J., Jan. 09, 2026 (GLOBE...
-
Den 23. oktober 2025 igangsatte Fast Ejendom Danmark A/S (”Selskabet”) et aktietilbagekøbsprogram. Aktietilbagekøbet løber i perioden fra og med den 24. oktober 2025 til og med den 23. oktober 2026....
-
Amstelveen, Netherlands, Jan. 09, 2026 (GLOBE NEWSWIRE) -- JBS N.V. (the “Company,” “JBS,” “we” or “us”) (NYSE: JBS; B3: JBSS32), reminds the holders of Old Notes (as defined below) that each...
-
Le 9 janvier 2026 Information relative au nombre total de droits de vote et d’actions composant le capital social Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Place de...
-
TUCSON, AZ, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Liberty Star Minerals | Liberty Star Uranium & Minerals Corp. (OTCQB: LBSR) a U.S. exploration company focused on strategic and commercially...
-
Dismissal of Federal Securities Class Action Lawsuit Follows Dismissal of Related Shareholder Derivative Lawsuit New York, NY, Jan. 09, 2026 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ:...
-
Aims to Build on Positive 2025 Interim TN-201 Results in First Half of 2026 with Longer-Term Follow-Up Data for Cohorts 1 and 2 from MyPEAK™-1 Trial of Adults with MYBPC3-Associated HCM Expects to...
-
Nutanix announced that its management will present at the 28th Annual Needham Growth Conference on Friday, January 16, at 8:00 AM PT / 11:00 AM ET.